What they were paid
Rapport Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $49,000 | $0 | $88,927 | $0 | $137,927 |
| FY2024 | $7,323 | $0 | $585,598 | $0 | $592,921 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Rapport Therapeutics, Inc. DEF 14A filed April 23, 2026, accession 0001193125-26-171828, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Rapport Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themCompensation · Science and Technology
The rest of the Rapport Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Abraham N. Ceesay | Director | $0 |
| James I. Healy | Independent Director | $235,355 |
| John Maraganore | Independent Director | $230,355 |
| Paul M. Silva | Independent Director | $147,927 |
| Reid Huber | Independent Director | $221,855 |
| Robert J. Perez | Independent Director | $141,927 |
| Steven M. Paul | Independent Director | $221,855 |
| Wendy B. Young | Independent Director | $136,927 |
The full Rapport Therapeutics compensation record
free company briefThis page is one director within Rapport Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat